Furthermore, even in the presence of lactate, breast cancer cells expressing WNT5A showed a statistically significant reduced level of MCT1 as compared to lactate treated MDA-MB-468-EV cells (p = 0.006) (Figure 7B). This evidence concerns the gene SLC16A1 and breast cancer.